Biotech news
Refine search
Pharma
Frank Kalkbrenner was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 28 August 2018
Americas
Bryan Roberts was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 27 August 2018
Americas
Jim Tananbaum was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 24 August 2018
Americas
Craig Muir was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 23 August 2018
Pharma
Pharmaceutical company AbbVie has signed an exclusive licensing agreement with biotech group Argenx to develop and commercialise immuno-oncology antibody ARGX-115. 23 August 2018
Americas
The US District Court for the District of Nebraska has dismissed counterclaims made against Farmers Edge in its trade secrets dispute with a competitor, according to a statement shared by the Canadian company. 22 August 2018
Biotech
Martyn Andrews was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the legal section, as LSIPR reports. 21 August 2018
Asia-Pacific
Japan-based Astellas Pharma has acquired Quethera, a UK-headquartered gene therapy company focused on developing treatments for ocular disorders. 15 August 2018
Americas
AbbVie has taken Sandoz to court over its biosimilar version of Humira (adalimumab), heightening the dispute between the pair. 13 August 2018
Asia-Pacific
South Korea-based Samsung has revealed plans to commit W25 trillion to pursue new technology in areas including biopharmaceuticals and artificial intelligence. 10 August 2018